Working Group: Recommendations
- Does PCA3 Testing for the Diagnosis and Management of Prostate Cancer improve patient health outcomes?
- Testing for Cytochrome P450 Polymorphisms (CYP450) in Adults with Non-Psychotic Depression Prior to Treatment with Selective Serotonin Reuptake Inhibitors (SSRIs)
- Can UGT1A1 Genotyping Reduce Morbidity and Mortality in Patients with Metastatic Colorectal Cancer Treated with Irinotecan?
- Can tumor gene expression profiling improve outcomes in patients with breast cancer?
- Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
- Use of Genomic Profiling to Assess Risk for Cardiovascular Disease (CVD) and Identify Individualized Prevention Strategies
- Does genomic profiling to assess Type 2 Diabetes risk improve health outcomes?
- Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
- Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
Links to organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by EGAPP, and none should be inferred. EGAPP is not responsible for the content of the individual organization Web pages found at these links.
File Format Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Page last updated: September 27, 2013
Page last reviewed: May 15, 2013
Content Source: OPHG Staff